• Skip to primary navigation
  • Skip to main content

IMMUNOLOGY2024™

May 3–7, 2024 | Chicago, Illinois

  • Policies
  • Program
    • President’s Program
    • Distinguished Lectures
    • Major Symposia
    • Special Session
    • Committee Sponsored Sessions
    • Block Symposia
    • Poster Sessions
    • Award Presentations & Lectures
    • Career Development Sessions
    • Guest Sessions
    • AAI Business Meeting
    • Exhibitor Workshops
    • Social Events
  • Register
    • Registration FAQ
  • Hotels
  • Awards
  • Careers
    • For Job Seekers
    • For Employers
    • Jobs Board
  • Abstracts
    • Abstract FAQ
    • Submission Tips
    • Podium Presentation Guidelines
    • Poster Presentation Guidelines
    • Abstract Topic Categories
    • Major Symposium Guidance for Trainees
    • Abstract Policies and Procedures
    • Program Acknowledgements
  • Exhibitors
  • Sponsors
  • Resources
    • Attendee Social Media Toolkit
    • Presenter Social Media Toolkit
    • Podium Presentation Guidelines
    • Poster Presentation Guidelines
  • FAQ
    • General FAQ
    • Abstract FAQ
    • Registration FAQ
  • Show Search
Hide Search
 Monday, May 6, 2024     11:30 AM – 12:45 PM ET     Exhibit Hall F1

Peptide Selection and Downstream Effects on Immune Responses

Characteristics of tumor-rejecting neoantigens identified in a physiologically relevant cutaneous squamous cell carcinoma model

Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 851
Abstract ID: 4385

Presenting Author:
Karen Hastings, Univ. of Arizona Col. of Med., Phoenix, VA Phoenix Healthcare Sys.

Co-Authors:
Anngela C Adams, Univ. of Arizona Col. of Med., Phoenix; Anne M Macy, Univ. of Arizona Col. of Med., Phoenix; Elizabeth S Borden, Univ. of Arizona Col. of Med., Phoenix; Lauren M Herrmann, Univ. of Arizona Col. of Med., Phoenix; Chad A Brambley, Univ. of Notre Dame; Tao Ma, Mayo Clin., Arizona; Xing Li, Mayo Clin., Arizona; Alysia Hughes, Mayo Clin., Arizona; Denise J Roe, Univ. of Arizona; Aaron Mangold, Mayo Clin., Arizona; Kenneth H Buetow, Arizona State Univ.; Melissa A Wilson, Arizona State Univ.; Brian M Baker, Univ. of Notre Dame


HLA-DO’s effect on exogenous antigen presentation

Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 853
Abstract ID: 4301

Presenting Author:
Karthik M Ramesh, UMass Chan Med. Sch.

Co-Authors:
Padma P Nanaware, Weill Cornell Med.; Lawrence J Stern, UMass Chan Med. Sch.


High sequence diversity at the MHC class II genes in the Atlantic herring resolved by long-read sequencing

Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 855
Abstract ID: 4621

Presenting Author:
Minal Jamsandekar, Texas A&M Univ.


Exploring engineered HLA-I chaperones for enhancing the immunogenicity of cold tumors.

Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 857
Abstract ID: 4889

Presenting Author:
Daniel Hwang, Children’s Hosp. of Philadelphia

Co-Authors:
Shirley Sun, Univ. of Pennsylvania; Nikolaos G. Sgourakis, Univ. of Pennsylvania


Modulation of antigen presentation by first-in-class ERAP1 and ERAP2 inhibitors for the treatment of cancer and autoimmunity

Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 859
Abstract ID: 5160

Presenting Author:
Kristopher Clark, Grey Wolf Therapeut.

Co-Authors:
Kate Anderton, Grey Wolf Therapeut.; Wayne Paes, Grey Wolf Therapeut.; Daniel Green, Grey Wolf Therapeut.; Faraz Khan, Grey Wolf Therapeut.; Nicola Ternette, Univ. of Oxford; Tsang Wai Lam, Pivot Park Screening Ctr.; Jesse Wat, Pivot Park Screening Ctr.; Maaike Bras, Pivot Park Screening Ctr.; Tobias Trelber, Biognosys; Anamarija Pfeiffer, Biognosys; Dan Redfern, Biognosys; Annaig Rozo, Sygnature Discovery; Joud Sabouni, Sygnature Discovery; Samantha Garside, Sygnature Discovery; Steven Kay, Sygnature Discovery; Jason Shiers, Sygnature Discovery; Martin Quibell, Grey Wolf Therapeut.; Peter Joyce, Grey Wolf Therapeut.


Airway epithelial cells enhance the Th2 cell-stimulating activity of lung dendritic cells

Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 861
Abstract ID: 5237

Presenting Author:
Hideki Nakano, NIEHS, NIH

Co-Authors:
Christina L Wilkinson, NIEHS, NIH; Keiko Nakano, NIEHS, NIH; Gregory S Whitehead, NIEHS, NIH; Sara A Grimm, NIEHS, NIH; Donald N Cook, NIEHS, NIH


Improved identification of allele-specific MHC class II immunopeptidome

Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 865
Abstract ID: 5742

Presenting Author:
Julie M Rumble, Cayman Chem. Co.

Co-Authors:
Seeta Nyayapathy, Cayman Chem. Co.; Richard Jones, MS Bioworks; Paul Good, Cayman Chem. Co.; Bill Ho, Cayman Chem. Co.


Human ERAP2 polymorphisms elicit differentiated antigen processing in response to virus

Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 867
Abstract ID: 6063

Presenting Author:
J David Peske, Johns Hopkins Univ. Sch. of Med.

Co-Authors:
Matin Bikaran, UCSF; Supriya Agarwal, UCSF; Adrian Martin Esteban, Johns Hopkins Univ. Sch. of Med.; Luca Valdivia, Johns Hopkins Univ. Sch. of Med.; Peter Rhee, Johns Hopkins Univ. Sch. of Med.; Jesus Contreras Rodriguez, Johns Hopkins Univ. Sch. of Med.; Charlotte Hurabielle, UCSF; David Lee, UCSF; Thomas Mazumder, UCSF; Taibo Lit, UCSF; Shiyun Feng, UCSF; Holly Steininger, UCSF; Yang Sun, UCSF; Aditya Jangid, UCSF; Scheherazade Sadegh-Nasseri, UCSF; Yun Song, Univ. of California, Berkeley; Nilabh Shastri, Johns Hopkins Univ. Sch. of Med.; Chun Jimmie Ye, UCSF

AAI Logo

Footer

IMMUNOLOGY2024™

May 3–7, 2024
McCormick Place
Chicago, Illinois, USA

Copyright © 2025 The American Association of Immunologists. All rights reserved.